(Q37118963)

18 August 2017

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes (English)

1 reference

18 August 2017

1 reference

Torbjörn Kullenberg

1

1 reference

18 August 2017

Malin Löfqvist

2

1 reference

18 August 2017

Mika Leinonen

3

1 reference

18 August 2017

Raphaela Goldbach-Mansky

4

1 reference

18 August 2017

Hans Olivecrona

5

1 reference

18 August 2017

3 May 2016

1 reference

18 August 2017

1 reference

18 August 2017

55

1 reference

18 August 2017

8

1 reference

18 August 2017

1499-1506

1 reference

Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

The emerging role of interleukin-1β in autoinflammatory diseases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Anakinra for rheumatoid arthritis: a systematic review

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Anakinra for rheumatoid arthritis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

The inflammasome: first line of the immune response to cell stress

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

The epidemiology of acute respiratory infections in children and adults: a global perspective

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4957676

Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS)

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27143789

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27143789

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/RHEUMATOLOGY/KEW208

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

27143789

1 reference